Group 1 - The company, Shandong Water Development Energy (00750), has successfully completed the issuance of bonds for 2025, raising up to RMB 1.5 billion from professional investors [1] - The bonds have a maturity period of five years, with a coupon rate ranging from 3.03% to 3.45% [1] - At the end of the third year, the company has the right to adjust the coupon rate, while bondholders have the right to exercise a put option [1]

Core Viewpoint - Water Development Industry Energy (00750) has successfully completed the issuance of bonds to professional investors, raising up to RMB 1.5 billion with a five-year maturity and an interest rate between 3.03% and 3.45% [1] Group 1 - The company has issued all bonds under the registered issuance scale of no more than RMB 1.5 billion [1] - The bonds have a maturity period of five years [1] - The coupon rate for the bonds ranges from 3.03% to 3.45% [1] Group 2 - The company will have the right to adjust the coupon rate at the end of the third year [1] - Bondholders will have the right to exercise a put option [1]

Core Viewpoint - China Resources Pharmaceutical (03320) has successfully completed the public issuance of the second phase of its 2025 corporate bonds, raising a total principal amount of RMB 1.1 billion with a maturity of 3 years and an annual coupon rate of 1.78% [1] Group 1 - The total principal amount of the second phase of the 2025 corporate bonds issued is RMB 1.1 billion [1] - The bonds have a maturity period of 3 years and a coupon rate of 1.78% [1] - The net proceeds from the bond issuance will be used for productive expenditures, including debt repayment, working capital supplementation, project development and operational expenses, investments related to technological innovation, and other uses compliant with applicable laws and regulations [1]

Core Viewpoint - China Resources Pharmaceutical (03320.HK) has successfully completed the public issuance of the second phase of its 2025 corporate bonds, raising a total principal amount of RMB 1.1 billion with a three-year term and an annual coupon rate of 1.78% [1] Group 1 - The total principal amount of the second phase of the 2025 corporate bonds issued is RMB 1.1 billion [1] - The bonds have a maturity period of three years and an annual interest rate of 1.78% [1] - The net proceeds from the bond issuance will be used for productive expenditures, including debt repayment, working capital supplementation, project development and operational expenses, investments related to technological innovation, and other uses compliant with applicable laws and regulations [1]

Core Viewpoint - China Resources Pharmaceutical (03320) has issued the first phase of its 2025 corporate bonds totaling RMB 1.1 billion, with a three-year term and an annual coupon rate of 1.82% [1] Summary by Relevant Categories Financial Details - The total principal amount of the issued bonds is RMB 1.1 billion [1] - The bonds have a maturity period of three years [1] - The coupon rate for the bonds is set at 1.82% per annum [1] Use of Proceeds - The net proceeds from the bond issuance will be utilized for productive expenditures [1] - Specific uses include debt repayment, working capital supplementation, project development and operational expenses, investments related to technological innovation, and other purposes compliant with applicable laws and regulations [1]

Core Viewpoint - China Resources Pharmaceutical (03320) has issued the first phase of its 2025 corporate bonds totaling RMB 1.1 billion, with a three-year term and an annual coupon rate of 1.82% [1] Summary by Categories Financial Details - The total principal amount of the issued bonds is RMB 1.1 billion [1] - The bonds have a maturity period of three years [1] - The coupon rate for the bonds is set at 1.82% per annum [1] Use of Proceeds - The net proceeds from the bond issuance will be utilized for productive expenditures [1] - Specific uses include debt repayment, working capital supplementation, project development and operational expenses, investments related to technological innovation, and other purposes compliant with applicable laws and regulations [1]

Group 1 - The company plans to publicly issue bonds with a face value of 100 yuan, totaling no more than 2 billion yuan [1] - The bond term will not exceed 5 years, with specific types and term structures to be determined based on market conditions [1] - The raised funds will be used for supplementing working capital, repaying interest-bearing liabilities, purchasing fixed assets, or other compliant purposes [1]